Loading market dashboard

Financials in GBp. Standardized financial statements.
A compact view of how Diaceutics PLC turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £38.44M | £32.16M | £23.70M | £19.50M | £13.94M | £12.70M | £13.44M | £10.37M | £7.37M | £4.59M |
| Revenue Growth? | +19.5% | +35.7% | +21.5% | +39.9% | +9.8% | -5.6% | +29.6% | +40.7% | +60.6% | 0.0% |
| Cost of Revenue? | £12.77M | £3.89M | £3.99M | £5.47M | £3.38M | £3.36M | £3.13M | £3.57M | £2.48M | £1.93M |
| Gross Profit? | £25.67M | £28.27M | £19.71M | £14.04M | £10.57M | £9.33M | £10.31M | £6.80M | £4.89M | £2.66M |
| Gross Margin? | +66.8% | +87.9% | +83.2% | +72.0% | +75.8% | +73.5% | +76.7% | +65.6% | +66.3% | +57.9% |
| Operating Expenses? | £25.88M | £30.73M | £22.72M | £13.71M | £10.25M | £9.94M | £8.19M | £5.59M | £3.99M | £1.77M |
| Operating Income? | -£212,000 | -£2.46M | -£3.02M | £575,000 | £550,000 | -£610,000 | £2.12M | £1.21M | £901,246 | £882,286 |
| EBITDA? | £5.60M | £2.77M | £2.36M | £3.61M | £2.35M | £178,000 | £847,581 | £1.30M | £922,178 | £584,172 |
| Income Before Tax | £302,000 | -£1.91M | -£2.44M | £564,000 | £462,000 | -£929,000 | £340,324 | £877,264 | £784,857 | £784,975 |
| Income Tax Expense | £205,000 | -£205,000 | -£692,000 | -£160,000 | -£99,000 | -£1.19M | -£57,557 | £244,957 | £121,664 | £37,836 |
| Net Income? | £97,000 | -£1.70M | -£1.75M | £724,000 | £561,000 | £263,000 | £398,000 | £632,307 | £663,193 | £747,139 |
| EPS? | £0.00 | £-0.02 | £-0.02 | £0.01 | £0.01 | £0.00 | £0.01 | £0.01 | £0.01 | £0.01 |
| Diluted EPS? | £0.00 | £-0.02 | £-0.02 | £0.01 | £0.01 | £0.00 | £0.01 | £0.01 | £0.01 | £0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality